Update: 20.01.2026
Last week: 5 week 2026 (26.01.2026 - 01.02.2026)
Last full month: January 2026
| Time period | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | |||||||||
| WoW | 8 949 | 0.0% | 14.7% | 0.4 | 21 465 851 | 0.4% | 11.3% | 0.4 | -3.0% |
| MoM | 34 466 | -23.7% | 14.6% | -0.6 | 82 352 118 | -23.0% | 11.2% | -0.3 | -20.5% |
| YTD | 39 456 | 3.1% | 14.6% | 1.6 | 94 258 148 | 20.3% | 11.2% | 1.8 | -8.3% |
| MAT | 495 261 | 15.6% | 13.9% | 1.4 | 1 133 655 517 | 33.7% | 10.4% | 1.2 | 4.0% |
| BRAINMAX | |||||||||
| WoW | 7 166 | -14.7% | 100.0% | 0 | 10 688 911 | -13.3% | 100.0% | 0 | -14.7% |
| MoM | 31 101 | 17.9% | 100.0% | 0 | 44 921 572 | 13.7% | 100.0% | 0 | 17.9% |
| YTD | 34 456 | 258.6% | 100.0% | 0 | 49 932 208 | 45.9% | 100.0% | 0 | 258.6% |
| MAT | 186 977 | 113.8% | 100.0% | 0 | 450 204 594 | 48.2% | 100.0% | 0 | 113.8% |
| GOLDLINE PLUS | |||||||||
| WoW | 12 900 | -5.1% | 44.5% | 0.2 | 42 836 151 | -3.6% | 37.2% | 1.2 | -5.5% |
| MoM | 54 871 | -4.1% | 45.4% | -1.1 | 179 253 369 | -4.6% | 37.2% | -1.6 | -1.8% |
| YTD | 62 283 | -14.5% | 45.4% | 0 | 203 778 601 | -13.6% | 37.2% | -0.4 | -14.4% |
| MAT | 749 483 | -9.2% | 45.9% | 0.3 | 2 447 053 120 | -5.5% | 37.8% | 0.4 | -9.8% |
| MIGRENIUM | |||||||||
| WoW | 9 488 | -10.1% | 0.4% | 0 | 3 402 422 | -9.5% | 0.6% | 0 | -1.9% |
| MoM | 43 517 | 0.1% | 0.5% | 0.1 | 15 546 969 | 1.3% | 0.6% | 0.1 | -20.3% |
| YTD | 49 725 | 32.6% | 0.4% | 0.1 | 17 749 882 | 35.7% | 0.6% | 0.1 | 2.4% |
| MAT | 447 336 | -18.3% | 0.4% | -0.1 | 159 040 553 | -11.4% | 0.5% | -0.1 | 5.6% |
| MODELAX-N | |||||||||
| WoW | 24 278 | -5.5% | 16.4% | -0.5 | 14 987 951 | -5.9% | 12.5% | -0.5 | -2.3% |
| MoM | 108 364 | -12.9% | 17.4% | -1 | 67 044 194 | -13.0% | 13.2% | -0.9 | -8.1% |
| YTD | 125 942 | -15.0% | 17.6% | -3.5 | 77 982 608 | 2.4% | 13.4% | -1.4 | 2.1% |
| MAT | 1 415 791 | -4.0% | 19.3% | -2.5 | 807 407 477 | 18.6% | 14.3% | -0.1 | 8.2% |
| RAITBUFEN | |||||||||
| WoW | 1 640 | -30.9% | 0.1% | 0 | 774 181 | -31.0% | 0.1% | -0.1 | -2.8% |
| MoM | 7 162 | 130.7% | 0.1% | 0.1 | 3 377 272 | 122.3% | 0.1% | 0.1 | -17.5% |
| YTD | 7 717 | Inf | 0.1% | 0.1 | 3 647 615 | Inf | 0.1% | 0.1 | 2.4% |
| MAT | 13 670 | Inf | 0.0% | 0 | 6 430 320 | Inf | 0.0% | 0 | 6.7% |
| REDUXIN | |||||||||
| WoW | 9 048 | -10.4% | 31.2% | -1.7 | 49 253 625 | -12.1% | 42.7% | -2.7 | -5.5% |
| MoM | 38 137 | 4.8% | 31.6% | 2 | 209 493 497 | 6.0% | 43.5% | 2.7 | -1.8% |
| YTD | 43 068 | -15.3% | 31.4% | -0.3 | 236 710 322 | -13.0% | 43.2% | -0.1 | -14.4% |
| MAT | 511 597 | -12.7% | 31.4% | -1 | 2 788 144 542 | -10.4% | 43.0% | -1.8 | -9.8% |
| REDUXIN FORTE | |||||||||
| WoW | 2 878 | -3.4% | 9.9% | 0.2 | 14 516 026 | -0.3% | 12.6% | 0.8 | -5.5% |
| MoM | 11 661 | -4.0% | 9.6% | -0.2 | 59 020 577 | -5.4% | 12.3% | -0.6 | -1.8% |
| YTD | 13 365 | -15.3% | 9.7% | -0.1 | 67 983 516 | -4.2% | 12.4% | 1.1 | -14.4% |
| MAT | 166 299 | -1.2% | 10.2% | 0.9 | 788 896 107 | 8.5% | 12.2% | 1.7 | -9.8% |
| SALVISAR | |||||||||
| WoW | 11 388 | -10.1% | 1.7% | -0.1 | 6 900 638 | -9.0% | 1.9% | -0.1 | -4.0% |
| MoM | 51 526 | -3.2% | 1.8% | 0.2 | 30 763 455 | 0.7% | 2.0% | 0.2 | -12.2% |
| YTD | 58 494 | -5.4% | 1.8% | 0 | 34 847 334 | 19.6% | 1.9% | 0.3 | -6.5% |
| MAT | 621 580 | 4.5% | 1.7% | 0.1 | 332 638 211 | 29.6% | 1.7% | 0.3 | -2.6% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | 39 456 | 3.1% | 14.6% | 1.6 | 94 258 148 | 20.3% | 11.2% | 1.8 | -8.3% |
| BRAINMAX | 34 456 | 258.6% | 100.0% | 0 | 49 932 208 | 45.9% | 100.0% | 0 | 258.6% |
| GOLDLINE PLUS | 62 283 | -14.5% | 45.4% | 0 | 203 778 601 | -13.6% | 37.2% | -0.4 | -14.4% |
| MIGRENIUM | 49 725 | 32.6% | 0.4% | 0.1 | 17 749 882 | 35.7% | 0.6% | 0.1 | 2.4% |
| MODELAX-N | 125 942 | -15.0% | 17.6% | -3.5 | 77 982 608 | 2.4% | 13.4% | -1.4 | 2.1% |
| RAITBUFEN | 7 717 | Inf | 0.1% | 0.1 | 3 647 615 | Inf | 0.1% | 0.1 | 2.4% |
| REDUXIN CAPS | 43 068 | -15.3% | 31.4% | -0.3 | 236 710 322 | -13.0% | 43.2% | -0.1 | -14.4% |
| REDUXIN FORTE | 13 365 | -15.3% | 9.7% | -0.1 | 67 983 516 | -4.2% | 12.4% | 1.1 | -14.4% |
| SALVISAR | 58 494 | -5.4% | 1.8% | 0 | 34 847 334 | 19.6% | 1.9% | 0.3 | -6.5% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | 495 261 | 15.6% | 13.9% | 1.4 | 1 133 655 517 | 33.7% | 10.4% | 1.2 | 4.0% |
| BRAINMAX | 186 977 | 113.8% | 100.0% | 0 | 450 204 594 | 48.2% | 100.0% | 0 | 113.8% |
| GOLDLINE PLUS | 749 483 | -9.2% | 45.9% | 0.3 | 2 447 053 120 | -5.5% | 37.8% | 0.4 | -9.8% |
| MIGRENIUM | 447 336 | -18.3% | 0.4% | -0.1 | 159 040 553 | -11.4% | 0.5% | -0.1 | 5.6% |
| MODELAX-N | 1 415 791 | -4.0% | 19.3% | -2.5 | 807 407 477 | 18.6% | 14.3% | -0.1 | 8.2% |
| RAITBUFEN | 13 670 | Inf | 0.0% | 0 | 6 430 320 | Inf | 0.0% | 0 | 6.7% |
| REDUXIN CAPS | 511 597 | -12.7% | 31.4% | -1 | 2 788 144 542 | -10.4% | 43.0% | -1.8 | -9.8% |
| REDUXIN FORTE | 166 299 | -1.2% | 10.2% | 0.9 | 788 896 107 | 8.5% | 12.2% | 1.7 | -9.8% |
| SALVISAR | 621 580 | 4.5% | 1.7% | 0.1 | 332 638 211 | 29.6% | 1.7% | 0.3 | -2.6% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | 8 949 | 0.0% | 14.7% | 0.4 | 21 465 851 | 0.4% | 11.3% | 0.4 | -3.0% |
| BRAINMAX | 7 166 | -14.7% | 100.0% | 0 | 10 688 911 | -13.3% | 100.0% | 0 | -14.7% |
| GOLDLINE PLUS | 12 900 | -5.1% | 44.5% | 0.2 | 42 836 151 | -3.6% | 37.2% | 1.2 | -5.5% |
| MIGRENIUM | 9 488 | -10.1% | 0.4% | 0 | 3 402 422 | -9.5% | 0.6% | 0 | -1.9% |
| MODELAX-N | 24 278 | -5.5% | 16.4% | -0.5 | 14 987 951 | -5.9% | 12.5% | -0.5 | -2.3% |
| RAITBUFEN | 1 640 | -30.9% | 0.1% | 0 | 774 181 | -31.0% | 0.1% | -0.1 | -2.8% |
| REDUXIN CAPS | 9 048 | -10.4% | 31.2% | -1.7 | 49 253 625 | -12.1% | 42.7% | -2.7 | -5.5% |
| REDUXIN FORTE | 2 878 | -3.4% | 9.9% | 0.2 | 14 516 026 | -0.3% | 12.6% | 0.8 | -5.5% |
| SALVISAR | 11 388 | -10.1% | 1.7% | -0.1 | 6 900 638 | -9.0% | 1.9% | -0.1 | -4.0% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | 34 466 | -23.7% | 14.6% | -0.6 | 82 352 118 | -23.0% | 11.2% | -0.3 | -20.5% |
| BRAINMAX | 31 101 | 17.9% | 100.0% | 0 | 44 921 572 | 13.7% | 100.0% | 0 | 17.9% |
| GOLDLINE PLUS | 54 871 | -4.1% | 45.4% | -1.1 | 179 253 369 | -4.6% | 37.2% | -1.6 | -1.8% |
| MIGRENIUM | 43 517 | 0.1% | 0.5% | 0.1 | 15 546 969 | 1.3% | 0.6% | 0.1 | -20.3% |
| MODELAX-N | 108 364 | -12.9% | 17.4% | -1 | 67 044 194 | -13.0% | 13.2% | -0.9 | -8.1% |
| RAITBUFEN | 7 162 | 130.7% | 0.1% | 0.1 | 3 377 272 | 122.3% | 0.1% | 0.1 | -17.5% |
| REDUXIN CAPS | 38 137 | 4.8% | 31.6% | 2 | 209 493 497 | 6.0% | 43.5% | 2.7 | -1.8% |
| REDUXIN FORTE | 11 661 | -4.0% | 9.6% | -0.2 | 59 020 577 | -5.4% | 12.3% | -0.6 | -1.8% |
| SALVISAR | 51 526 | -3.2% | 1.8% | 0.2 | 30 763 455 | 0.7% | 2.0% | 0.2 | -12.2% |
ОБОЗНАЧЕНИЯ
WoW - Week Over Week - показатели для сравнения результатов текущей и предыдущей недели
MoM - Month Over Month - показатели для сравнения результатов последнего полного месяца и предыдущего полного месяца
YTD - Year to Date - показатели для сравнения результатов за период времени, начинающийся с первого дня текущего календарного года до текущей даты с результатами за сопоставимый период прошлого года
MAT - Moving Annual Total - показатели для сравнения результатов за период 12 месяцев, с датой окончания на последней доступной неделе, с результатами за сопоставимый период прошлого года
MS - Market Share - Доля рынка = (Продажи бренда / Продажи категории)*100%
Change, % = (Продажи бренда за последний период / Продажи бренда за предыдущий период - 1)*100%
Change, p.p. = Доля бренда на рынке за последний период - Доля бренда на рынке за предыдущий период (выражается в процентных пунктах)
Cat. Volume Change, % = (Продажи категории в упаковках за последний период / Продажи категории в упаковках за предыдущий период - 1)*100%
Каждая категория собрана специально для каждого бренда и включает в себя бренд и его конкурентов
Список конкурентов можно найти в разделе “MS of competitors” в блоке каждого бренда
ABBREVIATIONS
WoW - Week Over Week - indicators for comparing the results of the current and previous week
MoM - Month Over Month - indicators for comparing the results of the* last full month* and previous full month
YTD - Year to Date - indicators for comparing the results of the period of time beginning the first day of the current calendar year up to the current date with the results of the comparable period last year
MAT - Moving Annual Total - indicators for comparing the results of the period, being 12 month period ending on the last week with the results of the comparable period last year
MS - Market Share - (Brand Sales / Category Sales)*100%
Change, % = (Brand Sales of the last period / Brand Sales of the previous period - 1)*100%
Change, p.p. = Brand Market Share of the last period - Brand Market Share of the previous period (expressed in percentage points)
Cat. Volume Change, % = (Category Sales in packs of the last period / Category Sales in packs of the previous period - 1)*100%
Each category is created specifically for each brand and includes the brand and its competitors
The list of competitors can be found in the subsection “MS of competitors” in sections for each brand
## [1] "MODELAX-N"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #2"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #4"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #8"
## [1] "MODELAX-N SOL RECTAL USE 12.9 MG/ML+102.6 MG/ML+625 MG/ML 5 ML #20"
## [1] "MODELAX-N"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #2"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #4"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #8"
## [1] "MODELAX-N SOL RECTAL USE 12.9 MG/ML+102.6 MG/ML+625 MG/ML 5 ML #20"
## [1] "AMBENE BIO"
## [1] "AMBENE BIO SOL FOR INJ 1 ML #10"
## [1] "AMBENE BIO SOL FOR INJ 2 ML #5"
## [1] "AMBENE BIO"
## [1] "AMBENE BIO SOL FOR INJ 1 ML #10"
## [1] "AMBENE BIO SOL FOR INJ 2 ML #5"
## [1] "MIGRENIUM"
## [1] "MIGRENIUM COATED TABLETS 65 MG+500 MG #20"
## [1] "MIGRENIUM NEO COATED TABLETS 400 MG+100 MG #10"
## [1] "MIGRENIUM NEO COATED TABLETS 400 MG+100 MG #20"
## [1] "MIGRENIUM"
## [1] "MIGRENIUM COATED TABLETS 65 MG+500 MG #20"
## [1] "MIGRENIUM NEO COATED TABLETS 400 MG+100 MG #10"
## [1] "MIGRENIUM NEO COATED TABLETS 400 MG+100 MG #20"
## [1] "RAITBUFEN"
## [1] "RAITBUFEN COATED TABLETS 400 MG #10"
## [1] "RAITBUFEN COATED TABLETS 400 MG #20"
## [1] "RAITBUFEN"
## [1] "RAITBUFEN COATED TABLETS 400 MG #10"
## [1] "RAITBUFEN COATED TABLETS 400 MG #20"
## [1] "SALVISAR"
## [1] "SALVISAR UNGUENT FOR EXT USE 100 G #1"
## [1] "SALVISAR UNGUENT FOR EXT USE 25 G #1"
## [1] "SALVISAR UNGUENT FOR EXT USE 25 G #2"
## [1] "SALVISAR UNGUENT FOR EXT USE 50 G #1"
## [1] "SALVISAR"
## [1] "SALVISAR UNGUENT FOR EXT USE 100 G #1"
## [1] "SALVISAR UNGUENT FOR EXT USE 25 G #1"
## [1] "SALVISAR UNGUENT FOR EXT USE 25 G #2"
## [1] "SALVISAR UNGUENT FOR EXT USE 50 G #1"
## [1] "REDUXIN CAPS"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #10"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #30"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #60"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #60"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #60"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #30"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #60"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #90"
## [1] "REDUXIN CAPS"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #10"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #30"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #60"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #90"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #10"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #30"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #60"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #90"
## [1] "REDUXIN FORTE"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #30"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #60"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #90"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #90"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #90"
## [1] "REDUXIN FORTE TABS 850 MG + 10 MG #90"
## [1] "REDUXIN FORTE"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #30"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #60"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #90"
## [1] "REDUXIN FORTE TABS 850 MG + 10 MG #30"
## [1] "REDUXIN FORTE TABS 850 MG + 10 MG #60"
## [1] "REDUXIN FORTE TABS 850 MG + 10 MG #90"
## [1] "GOLDLINE PLUS"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #10"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #30"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #30"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #90"
## [1] "GOLDLINE PLUS"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #10"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #30"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #90"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #10"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #30"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #90"
## [1] "BRAINMAX"
## [1] "BRAINMAX CAPS 250 MG+250 MG #20"
## [1] "BRAINMAX CAPS 250 MG+250 MG #40"
## [1] "BRAINMAX CAPS 250 MG+250 MG #60"
## [1] "BRAINMAX SOL FOR INTRAVEN&INTRAMUSC INJ 100 MG/ML+100 MG/ML 2,5 ML #10"
## [1] "BRAINMAX SOL FOR INTRAVEN&INTRAMUSC INJ 100 MG/ML+100 MG/ML 5 ML #10"
## [1] "BRAINMAX"
## [1] "BRAINMAX CAPS 250 MG+250 MG #20"
## [1] "BRAINMAX CAPS 250 MG+250 MG #40"
## [1] "BRAINMAX CAPS 250 MG+250 MG #60"
## [1] "BRAINMAX SOL FOR INTRAVEN&INTRAMUSC INJ 100 MG/ML+100 MG/ML 2,5 ML #10"
## [1] "BRAINMAX SOL FOR INTRAVEN&INTRAMUSC INJ 100 MG/ML+100 MG/ML 5 ML #10"
[RUS] ОБОЗНАЧЕНИЯ
WoW - Week Over Week - показатели для сравнения результатов текущей и предыдущей недели
MoM - Month Over Month - показатели для сравнения результатов последнего полного месяца и предыдущего полного месяца
YTD - Year to Date - показатели для сравнения результатов за период времени, начинающийся с первого дня текущего календарного года до текущей даты с результатами за сопоставимый период прошлого года
MAT - Moving Annual Total - показатели для сравнения результатов за период 12 месяцев, с датой окончания на последней доступной неделе, с результатами за сопоставимый период прошлого года
MS - Market Share - Доля рынка = (Продажи бренда / Продажи категории)*100%
Change, % = (Продажи бренда за последний период / Продажи бренда за предыдущий период - 1)*100%
Change, p.p. = Доля бренда на рынке за последний период - Доля бренда на рынке за предыдущий период (выражается в процентных пунктах)
Cat. Volume Change, % = (Продажи категории в упаковках за последний период / Продажи категории в упаковках за предыдущий период - 1)*100%
Каждая категория собрана специально для каждого бренда и включает в себя бренд и его конкурентов
Список конкурентов можно найти в разделе “MS of competitors” в блоке каждого бренда
[ENG] ABBREVIATIONS
WoW - Week Over Week - indicators for comparing the results of the current and previous week
MoM - Month Over Month - indicators for comparing the results of the last full month and previous full month
YTD - Year to Date - indicators for comparing the results of the period of time beginning the first day of the current calendar year up to the current date with the results of the comparable period last year
MAT - Moving Annual Total - indicators for comparing the results of the period, being 12 month period ending on the last week with the results of the comparable period last year
MS - Market Share - (Brand Sales / Category Sales)*100%
Change, % = (Brand Sales of the last period / Brand Sales of the previous period - 1)*100%
Change, p.p. = Brand Market Share of the last period - Brand Market Share of the previous period (expressed in percentage points)
Cat. Volume Change, % = (Category Sales in packs of the last period / Category Sales in packs of the previous period - 1)*100%
Each category is created specifically for each brand and includes the brand and its competitors
The list of competitors can be found in the subsection “MS of competitors” in sections for each brand
DATA SOURCES:
DSM: Sales
Palomars: TRPs